Marca Nominativa depositada no INPI em 16/04/2024 por Promega Corporation, processo nº 501804225, nas classes 01, 05. Registro em vigor até 16/04/2034.
| Número do processo | 501804225 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 16/04/2024 |
| Data da concessão | 06/01/2026 |
| Vigência até | 16/04/2034 |
| Titular | Promega Corporation |
| CNPJ/CPF do titular | — |
| UF · País | — · US |
Reagents for research purposes; reagents for non-medical purposes; reagents for the development and manufacture of cell and gene therapy products, namely cells, nucleic acids, and viral vectors and non-viral vectors in the nature of nucleic acid carriers, each of the aforementioned for scientific and research purposes; scientific or medical research reagents for laboratory use for providing enhanced accuracy and efficiency in vial genome titer data; small molecule reagents for scientific or medical research use; neutralization reagents for scientific or medical research use; reagents for use in polymerase chain reaction for scientific or medical research purposes, namely, nucleic acids, nucleotides, buffers, and enzymes; reagents for use in sterility assays for use in drug development and production.;
Reagents for use in medical genetic testing for providing enhanced accuracy and efficiency in vial genome titer data; small molecule reagents for medical use; neutralization reagents for medical use; reagents for use in polymerase chain reaction for medical genetic testing purposes, namely, nucleic acids, nucleotides, buffers, and enzymes.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501804225 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas3 despacho(s) publicado(s) na Revista da Propriedade Industrial.